We are live on ! Find out more
TGV

TRV GP V Portfolio holdings

AUM $401M
1-Year Est. Return 284.76%
This Fund
S&P 500
This Quarter Est. Return
-4.23%
1 Year Est. Return
+284.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$294M
AUM Growth
–
Cap. Flow
+$337M
Cap. Flow %
114.51%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RAPP
Rapport Therapeutics
RAPP
+$158M
2
SEPN
Septerna Inc
SEPN
+$147M
3
CRGX
CARGO Therapeutics
CRGX
+$31.5M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEPN
1
Septerna Inc
SEPN
$1.51B
$142M 48.42%
+6,215,591
New +$147M
RAPP
2
Rapport Therapeutics
RAPP
$2.01B
$127M 43.06%
+7,135,233
New +$158M
CRGX
3
DELISTED
CARGO Therapeutics
CRGX
$25.1M 8.52%
+1,737,216
New +$31.5M

Similar funds

SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
BLC
Brown, Lisle/Cummings Providence, Rhode Island $400M AUM 18.79% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
BWA
Beam Wealth Advisors Covington, Louisiana $402M AUM 20.08% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $402M AUM 10.33% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $402M AUM 17.05% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return

TRV GP V's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for TRV GP V, which disclosed 3 positions worth $294M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Rapport Therapeutics: 7,135,233 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • TRV GP V's largest Q4 2024 buy was Rapport Therapeutics: 7,135,233 shares worth $127M.
  • TRV GP V's ten largest holdings make up 100% of its $294M portfolio in Q4 2024.
  • TRV GP V disclosed 3 positions in Q4 2024, its first 13F filing on record.

Based on TRV GP V's 13F filing for Q4 2024, filed 13 Feb 2025.